This episode explores antiviral therapy and infection control principles. Drawing from Murray’s Chapter 40, it examines how antiviral agents differ fundamentally from antibacterial drugs - because viruses replicate within host cells and rely on host machinery.

The narrative organises antivirals by replication step:

* Entry inhibitors

* Uncoating inhibitors

* Polymerase inhibitors

* Reverse transcriptase inhibitors

* Protease inhibitors

* Integrase inhibitors

* Neuraminidase inhibitors

Unlike broad-spectrum antibiotics, antivirals are often highly specific to viral families, targeting unique enzymes or structural proteins.

The episode then widens to infection control: vaccination strategies, post-exposure prophylaxis, isolation protocols, and outbreak containment. Because viruses spread efficiently via respiratory droplets, contact, blood, or vectors, prevention is often as critical as treatment.

Conceptually, antiviral therapy is about precision interruption rather than eradication. Clinically, combination therapy and resistance monitoring are essential in chronic viral infections such as HIV and hepatitis.

Key Takeaways

* Antivirals target specific stages of viral replication

* Therapy often requires high specificity

* Combination regimens reduce resistance

* Vaccination remains the most powerful preventive tool

* Infection control interrupts transmission chains

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe